Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Jun 10;100(12):7051-6.
doi: 10.1073/pnas.1132112100. Epub 2003 May 29.

Toward a detailed computational model for the mammalian circadian clock

Affiliations

Toward a detailed computational model for the mammalian circadian clock

Jean-Christophe Leloup et al. Proc Natl Acad Sci U S A. .

Abstract

We present a computational model for the mammalian circadian clock based on the intertwined positive and negative regulatory loops involving the Per, Cry, Bmal1, Clock, and Rev-Erb alpha genes. In agreement with experimental observations, the model can give rise to sustained circadian oscillations in continuous darkness, characterized by an antiphase relationship between Per/Cry/Rev-Erbalpha and Bmal1 mRNAs. Sustained oscillations correspond to the rhythms autonomously generated by suprachiasmatic nuclei. For other parameter values, damped oscillations can also be obtained in the model. These oscillations, which transform into sustained oscillations when coupled to a periodic signal, correspond to rhythms produced by peripheral tissues. When incorporating the light-induced expression of the Per gene, the model accounts for entrainment of the oscillations by light-dark cycles. Simulations show that the phase of the oscillations can then vary by several hours with relatively minor changes in parameter values. Such a lability of the phase could account for physiological disorders related to circadian rhythms in humans, such as advanced or delayed sleep phase syndrome, whereas the lack of entrainment by light-dark cycles can be related to the non-24h sleep-wake syndrome. The model uncovers the possible existence of multiple sources of oscillatory behavior. Thus, in conditions where the indirect negative autoregulation of Per and Cry expression is inoperative, the model indicates the possibility that sustained oscillations might still arise from the negative autoregulation of Bmal1 expression.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Model for circadian oscillations in mammals involving interlocked negative and positive regulations of Per, Cry, Bmal1, and Rev-Erbα genes by their protein products. We focus on the case where BMAL1 exerts a direct negative feedback on the expression of its gene. The role of the Rev-Erbα gene product in the indirect regulation of Bmal1 expression by BMAL1 (indicated in gray) is considered in a second stage (the gray loop then replaces the direct negative feedback exerted by BMAL1). The kinetic equations governing the time evolution of the model are listed in Supporting Text, together with the definition and values of the parameters, given in the legend to Fig. 5 and in Table 1, respectively, which are published as supporting information on the PNAS web site, www.pnas.org.
Fig. 2.
Fig. 2.
Circadian oscillations in DD (A and B) and entrainment by LD cycles (C and D). (A) The mRNA of Bmal1 oscillates in antiphase with respect to the mRNAs of Per and Cry.(B) Corresponding oscillations of the PER, CRY, and BMAL1 proteins. (C) Oscillations of the mRNAs after entrainment by 12:12 LD cycles. The peak in Per mRNA occurs in the middle of the light phase. (D) Oscillations are delayed by 9 h and the peak in Per mRNA occurs in the dark phase when the value of parameter KAC is decreased from 0.6 to 0.4 nM. Other parameter values correspond to the basal set of values listed in Table 1. In C and D, the maximum value of the rate of Per expression, vsP, varies in a square-wave manner such that it remains at a constant low value of 1.5 nM/h during the 12-h-long dark phase (black rectangle) and is raised up to the high value of 1.8 nM/h during the 12-h-long light phase (white rectangle). The curves have been obtained by numerical integration of Eqs. 1–16 (see Supporting Text) of the model without REV-ERBα.
Fig. 3.
Fig. 3.
Relating the model to syndromes associated with disorders of the circadian oscillatory system. (A) Effect of the maximum rate of PER phosphorylation on the free running period in DD and on the phase of the oscillations in LD. The phase corresponds to the time (in h) at which the maximum in Per mRNA occurs after the onset of the light phase. Situations 1 and 2 show that different values of the control parameter can produce different phases after entrainment, even though they correspond to the same free running period in DD. Situation 1 corresponds to the entrainment shown in Fig. 2C. The double-arrow lines show how to obtain the free running period and the phase in LD for a given value of the control parameter. Situations a–c indicate that decreasing (increasing) the rate of phosphorylation, Vphos, with respect to the basal situation b can produce a phase advance (delay) as well as a decrease (increase) in the free running period. The transition from b to a would correspond to the phase shift observed in FASPS (see text). The gray areas on the left and right refer to absence of entrainment. The data are obtained by integration of Eqs. 1–16 (see Supporting Text) of the model without REV-ERBα, for the basal parameter values listed in Table 1, with Vphos = V1P = V1PC = V3PC. (B) Quasi-periodic behavior and phase jump outside the range of entrainment. The phase of the circadian oscillations does not lock to a constant value with respect to the 24-h LD cycle, as occurs in the case of entrainment (see Fig. 2 C and D). Instead, the phase advances every day by <1 h. During 25 successive days the peak in Per mRNA falls within the light phase of the LD cycle, until it reaches the end of the preceding dark phase. Then, in only 4 successive days (horizontal arrows), it crosses the dark phase and reaches the end of the preceding light phase. Gray and white bars represent the dark and light phases of the LD cycles, respectively. The curve in B has been obtained as in Fig. 2C, for the same parameter values except KIB = 1.64 nM instead of 2.2 nM.
Fig. 4.
Fig. 4.
The possibility of oscillations due to multiple oscillatory mechanisms. (A) The oscillations in Fig. 2 A disappear in the absence of PER protein synthesis (ksP = 0). The curves show the asymptotic, stable steady state reached after transients have subsided. (B) Sustained oscillations are restored in these conditions when the degree of cooperativity, m, of repression of Bmal1 by CLOCK-BMAL1 increases from 2 to 4. The fact that oscillations can occur in the absence of PER protein indicates the existence of another oscillatory mechanism that relies only on CLOCK-BMAL1 autoregulation. The curves are obtained by numerical integration of Eqs. 1–16 of the model without REV-ERBα, for the basal parameter values listed in Table 1, except ksP = 0, m = 4, ksB = 0.5 h-1; for this choice of parameter values, the period is 19.83 h. The period varies from some 12 h to 40 h as the rate constant, ksB, measuring BMAL1 synthesis decreases from 1.4 h-1 to 0.1 h-1. (C) Oscillations occurring solely due to the PER–CRY negative autoregulation can occur in the absence of negative feedback of BMAL1 on Bmal1 expression. The curves, showing the time evolution of Per, Cry, and Bmal1 mRNAs, were obtained as in Fig. 2 A, for the same parameter values except KIB = 100 nM (the effect of the negative feedback of BMAL1 on Bmal1 transcription is negligible at such a high value of the inhibition constant), vmB = 0.96 nM/h. The period of the oscillations is 23.91 h.

Similar articles

Cited by

References

    1. Young, M. W. & Kay, S. A. (2001) Nat. Rev. Genet. 2, 702-715. - PubMed
    1. Loros, J. J. & Dunlap, J. C. (2001) Annu. Rev. Physiol. 63, 757-794. - PubMed
    1. Mori, T. & Johnson, C. H. (2001) Semin. Cell Dev. Biol. 12, 271-278. - PubMed
    1. Roden, L. C. & Carre, I. A. (2001) Semin. Cell Dev. Biol. 12, 305-315. - PubMed
    1. Reppert, S. & Weaver, D. (2002) Nature 418, 935-941. - PubMed

Publication types

MeSH terms

Substances